Saturday, September 5, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· April 14, 2026

NeuroTrader Launches AI Crypto Trading Platform With Free Entry and Five Subscription Tiers

View original at globenewswire.com
NeuroTrader Launches AI Crypto Trading Platform With Free Entry and Five Subscription Tiers DELRAY BEACH, Fla., April 14, 2026 (GLOBE NEWSWIRE) -- NeuroTrader, a multi-AI decision intelligence system built on ensemble consensus, officially opens to the public with five subscription tiers starting at $0 per month…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Performance data will accumulate as the live environment scales

    60% confidence

  • Ensemble consensus architecture is designed to filter out the noise that causes single-model AI crypto bots to overtrade or misread market conditions

    60% confidence

  • NeuroTrader runs six independent intelligence engines in parallel and only executes a trade when multiple engines reach weighted agreement

    60% confidence

  • User funds never leave the exchange. API keys carry zero withdrawal permissions, are encrypted at rest with AES-256, and isolated per user

    60% confidence

  • NeuroTrader is not projecting guaranteed returns and the system is in its early activation phase

    60% confidence

  • Phase 3 Adaptive Intelligence Core is where the system shifts from executing predefined logic to evolving through its own performance data

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com